Lophos Pharmaceuticals Corp. CEO Claire Stawnyczy Presenting at O'Cannabiz Psychedelics Summit - June 2nd
Napanee, Ontario--(Newsfile Corp. - May 31, 2022) - Lophos Pharmaceuticals Corp., a Canadian biosciences research and development company that focuses on Peyote cultivation and Peyote derived compounds will be participating in the upcoming O'Cannabiz Psychedelic summit June 2nd at the International Centre Hall #5 in Mississauga, Ontario. CEO and President Claire Stawnyczy is proud to share her vision with conference attendees, in how she intends to build a sustainable pathway for medical...
2022-05-31 8:00 AM EDT
Peyote Research Company - Lophos Pharmaceuticals Corp. Presenting at Lift & Co Expo in Toronto
Toronto, Ontario--(Newsfile Corp. - May 10, 2022) - Lophos Pharmaceuticals Corp., a Canadian psychedelic research company is scheduled to present at the upcoming Lift & Co. Expo next week, Friday, May 13th. The feature presentation titled, "Nature's Medicine: Peyote's Place in the Psychedelic Industry," is scheduled for 11:30am.Claire Stawnyczy, President & CEO of Lophos Pharma, will present her plan to create sustainable peyote cultivation and affiliated chemical compound research. The...
2022-05-10 1:00 PM EDT
Psychedelic Research Company Lophos Pharmaceuticals Corp. Developing Sustainably-Grown Peyote in Canada
Toronto, Ontario--(Newsfile Corp. - April 28, 2022) - Lophos Pharmaceuticals Corp., Lophos is a Canadian psychedelic research company focused on peyote and its derivatives such as mescaline. Peyote, an endangered plant species with a long history of therapeutic use has legal status in Canada, but mescaline, a powerful psychedelic molecule derived from the plant, remains a Schedule 3 controlled substance. At their facility, Lophos Pharma will research improved cultivation techniques, while...
2022-04-28 8:00 AM EDT
Canadian Psychedelic Research Company Lophos Pharmaceuticals Inc. Engages KGK Science for Novel Peyote Study
Toronto, Ontario--(Newsfile Corp. - March 21, 2022) - Lophos Pharmaceuticals Inc., a Canadian psychedelic research company focused on cultivation and drug development, engages KGK Science Inc. to evaluate a path to market for sustainably-grown peyote-derived natural health products (NHPs). Peyote has legal status in Canada, but mescaline - the drug derived from the plant - remains a schedule 3 controlled substance."Lophos is currently exploring the potential benefits of a peyote-derived...
2022-03-21 8:00 AM EDT